Revista espanola de enfermedades digestivas · 2025
Fecal microbiota transplantation for prevention of recurrent acute cholangitis. Review of four published cases.
СтатьяКлинический случайОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ramos Martínez Antonio, Gutiérrez-Villanueva Andrea, González-Haba Ruiz Mariano, Diego-Yagüe Itziar, Nieto-Fernández Alberto, Muñez Elena, Fernández Cruz Ana, Calderón Parra Jorge
Аннотация
INTRODUCTION: recurrent acute cholangitis (RAC) constitutes a relevant clinical problem that may condition the prognosis of the patient. Chronic suppressive antibiotic therapy can be used for preventive purposes, but it is associated with adverse effects and can select resistant bacterial strains. Fecal microbiota transfer (FMT) has been shown to be effective to prevent recurrent Clostridioides difficile infection and could be a useful strategy in patients with RAC.
OBJECTIVE: to review the experience of the use of FMT in the prevention of episodes of RAC by reviewing published cases. This article is based on previously published cases without presenting new original clinical data.
RESULT: four cases were identified in which FMT significantly reduced RAC episodes. The patients were characterized by lack of efficacy of conventional treatments, had different predisposing factors for RAC and frequent colonization and infection by multidrug-resistant bacteria.
CONCLUSIONS: the four cases presented provide limited but encouraging evidence of the preventive effect of FMT on successive episodes in patients without biliary tract obstruction. Larger and more adequately designed studies will be necessary to deepen the knowledge of this possible preventive strategy.
OBJECTIVE: to review the experience of the use of FMT in the prevention of episodes of RAC by reviewing published cases. This article is based on previously published cases without presenting new original clinical data.
RESULT: four cases were identified in which FMT significantly reduced RAC episodes. The patients were characterized by lack of efficacy of conventional treatments, had different predisposing factors for RAC and frequent colonization and infection by multidrug-resistant bacteria.
CONCLUSIONS: the four cases presented provide limited but encouraging evidence of the preventive effect of FMT on successive episodes in patients without biliary tract obstruction. Larger and more adequately designed studies will be necessary to deepen the knowledge of this possible preventive strategy.